SSI
GILD icon

Scott & Selber Inc’s Gilead Sciences GILD Stock Holding History

Scott & Selber Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
10,397
-17
-0.2% -$2.24K 0.28% 66
2026
Q1 		$1.45M Sell
10,414
-34
-0.3% -$4.76K 0.37% 67
2025
Q4 		$1.28M Sell
10,448
-484
-4% -$58.8K 0.32% 71
2025
Q3 		$1.21M Sell
10,932
-135
-1% -$15.3K 0.31% 73
2025
Q2 		$1.23M Buy
11,067
+90
+0.8% +$9.58K 0.34% 72
2025
Q1 		$1.23M Sell
10,977
-2
-0% -$206 0.39% 70
2024
Q4 		$1.01M Buy
10,979
+7
+0.1% +$630 0.31% 73
2024
Q3 		$920K Sell
10,972
-86
-0.8% -$6.56K 0.29% 76
2024
Q2 		$759K Buy
11,058
+81
+0.7% +$5.41K 0.24% 78
2024
Q1 		$804K Sell
10,977
-71
-0.6% -$5.46K 0.27% 79
2023
Q4 		$895K Sell
11,048
-27
-0.2% -$2.1K 0.34% 80
2023
Q3 		$830K Sell
11,075
-22
-0.2% -$1.69K 0.34% 83
2023
Q2 		$855K Sell
11,097
-28
-0.3% -$2.23K 0.33% 84
2023
Q1 		$923K Buy
11,125
+38
+0.3% +$3.15K 0.39% 82
2022
Q4 		$952K Sell
11,087
-12
-0.1% -$950 0.43% 81
2022
Q3 		$685K Buy
11,099
+48
+0.4% +$3.03K 0.33% 87
2022
Q2 		$683K Sell
11,051
-740
-6% -$45.8K 0.31% 89
2022
Q1 		$701K Sell
11,791
-162
-1% -$10.4K 0.27% 90
2021
Q4 		$868K Buy
+11,953
New +$823K 0.31% 88
2016
Q2 		– Sell
-24,272
Closed -$2.23M – 66
2016
Q1 		$2.23M Buy
24,272
+91
+0.4% +$8.21K 1.49% 36
2015
Q4 		$2.45M Buy
24,181
+188
+0.8% +$19.6K 1.59% 31
2015
Q3 		$2.36M Buy
23,993
+42
+0.2% +$4.67K 1.74% 29
2015
Q2 		$2.8M Sell
23,951
-446
-2% -$48.7K 1.93% 23
2015
Q1 		$2.39M Sell
24,397
-1,368
-5% -$139K 1.62% 32
2014
Q4 		$2.43M Sell
25,765
-121
-0.5% -$12.5K 1.63% 35
2014
Q3 		$2.76M Sell
25,886
-18,631
-42% -$1.82M 1.92% 11
2014
Q2 		$3.69M Sell
44,517
-7
-0% -$545 2.45% 4
2014
Q1 		$3.15M Sell
44,524
-132
-0.3% -$10.4K 2.21% 9
2013
Q4 		$3.35M Buy
44,656
+32
+0.1% +$2.23K 2.45% 5
2013
Q3 		$2.81M Hold
44,624
– – 2.26% 5
2013
Q2 		$2.29M Buy
+44,624
New +$2.33M 2% 16

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Scott & Selber Inc's GILD Position: Q2 2026 in Review

Scott & Selber Inc reduced its Gilead Sciences (GILD) stake by 0.16% in Q2 2026, selling an estimated $2.24K and leaving 10,397 shares worth $1.31M. The position accounts for 0.28% of the portfolio, ranked #66.

Scott & Selber Inc first reported a position in GILD in Q2 2013 and has held it in 31 quarters since. The position peaked at $3.69M in Q2 2014. 646 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Scott & Selber Inc held 10,397 shares of Gilead Sciences worth $1.31M as of Q2 2026.
  • Scott & Selber Inc sold 17 Gilead Sciences shares in Q2 2026, an estimated $2.24K.
  • Gilead Sciences made up 0.28% of Scott & Selber Inc's portfolio in Q2 2026, its #66 holding.
  • Scott & Selber Inc first reported a position in Gilead Sciences in Q2 2013 and has held it in 31 quarters since.
  • Scott & Selber Inc's Gilead Sciences position peaked at $3.69M in Q2 2014.
  • 646 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Scott & Selber Inc's 13F filing for Q2 2026, filed 8 Jul 2026.